Russia's Pharmstandard acquires local manufacturer
This article was originally published in Scrip
Russia's only pharmaceutical manufacturer listed on the London Stock Exchange, Pharmstandard, has acquired the local drug producer Vindexpharm for an undisclosed sum. It said that it would finance the purchase from its own funds and that the deal should be closed by the end of this year. Local analysts estimated that it could be worth $20 million.